These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 25757761)

  • 1. Improved wall motion of late gadolinium-enhanced myocardium after complete surgical revascularization.
    Oh SJ; Park EA; Lee W; Hwang HY; Kim KB
    Ann Thorac Surg; 2015 May; 99(5):1554-60. PubMed ID: 25757761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serial cardiac magnetic resonance imaging after surgical coronary revascularization for left ventricular dysfunction.
    Hwang HY; Yeom SY; Park EA; Lee W; Jang MJ; Kim KB
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1798-1805. PubMed ID: 31301901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
    Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
    J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of cardiovascular magnetic resonance of late gadolinium enhancement and diastolic wall thickness to predict recovery of left ventricular function after coronary artery bypass surgery.
    Krittayaphong R; Laksanabunsong P; Maneesai A; Saiviroonporn P; Udompunturak S; Chaithiraphan V
    J Cardiovasc Magn Reson; 2008 Sep; 10(1):41. PubMed ID: 18808697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation.
    Glaveckaite S; Valeviciene N; Palionis D; Skorniakov V; Celutkiene J; Tamosiunas A; Uzdavinys G; Laucevicius A
    J Cardiovasc Magn Reson; 2011 Jul; 13(1):35. PubMed ID: 21787383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
    Kim RJ; Wu E; Rafael A; Chen EL; Parker MA; Simonetti O; Klocke FJ; Bonow RO; Judd RM
    N Engl J Med; 2000 Nov; 343(20):1445-53. PubMed ID: 11078769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Prognostic Value of Late Gadolinium-Enhanced Magnetic Resonance Imaging in Patients With and Without Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Grafting.
    Lee SA; Yoon YE; Kim JE; Park JJ; Oh IY; Yoon CH; Suh JW; Kim JS; Chun EJ; Cho YS; Youn TJ; Lim C; Cho GY; Chae IH; Park KH; Choi DJ; Choi SI
    Am J Cardiol; 2016 Dec; 118(11):1647-1654. PubMed ID: 27742424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe regional myocardial dysfunction by stress echocardiography does not predict the presence of transmural scarring in chronic coronary artery disease.
    Rösner A; Avenarius D; Malm S; Iqbal A; Bijnens B; Schirmer H
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1074-81. PubMed ID: 25920924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
    Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
    Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of delayed-enhancement cardiovascular magnetic resonance imaging in predicting myocardial viability after surgical revascularization.
    Selvanayagam JB; Kardos A; Francis JM; Wiesmann F; Petersen SE; Taggart DP; Neubauer S
    Circulation; 2004 Sep; 110(12):1535-41. PubMed ID: 15353496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of long-term segmental and global functional recovery of hibernating myocardium after revascularisation based on low dose dobutamine and late gadolinium enhancement cardiovascular magnetic resonance.
    Glaveckaite S; Valeviciene N; Palionis D; Puronaite R; Serpytis P; Laucevicius A
    J Cardiovasc Magn Reson; 2014 Oct; 16(1):83. PubMed ID: 25279683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Magnetic Resonance Predictor of Ventricular Function after Surgical Coronary Revascularization.
    Hwang HY; Yeom SY; Choi JW; Oh SJ; Park EA; Lee W; Kim KB
    J Korean Med Sci; 2017 Dec; 32(12):2009-2015. PubMed ID: 29115084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of myocardial viability by delayed-enhanced magnetic resonance in patients with coronary artery disease and low ejection fraction: impact of revascularization therapy.
    Gerber BL; Rousseau MF; Ahn SA; le Polain de Waroux JB; Pouleur AC; Phlips T; Vancraeynest D; Pasquet A; Vanoverschelde JL
    J Am Coll Cardiol; 2012 Feb; 59(9):825-35. PubMed ID: 22361403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance.
    Soriano CJ; Ridocci F; Estornell J; Jimenez J; Martinez V; De Velasco JA
    J Am Coll Cardiol; 2005 Mar; 45(5):743-8. PubMed ID: 15734620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete percutaneous revascularization for multivessel disease in patients with impaired left ventricular function: pre- and post-procedural evaluation by cardiac magnetic resonance imaging.
    Kirschbaum SW; Springeling T; Boersma E; Moelker A; van der Giessen WJ; Serruys PW; de Feyter PJ; van Geuns RJ
    JACC Cardiovasc Interv; 2010 Apr; 3(4):392-400. PubMed ID: 20398866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET/MRI early after myocardial infarction: evaluation of viability with late gadolinium enhancement transmurality vs. 18F-FDG uptake.
    Rischpler C; Langwieser N; Souvatzoglou M; Batrice A; van Marwick S; Snajberk J; Ibrahim T; Laugwitz KL; Nekolla SG; Schwaiger M
    Eur Heart J Cardiovasc Imaging; 2015 Jun; 16(6):661-9. PubMed ID: 25680385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy.
    Smith BM; Dorfman AL; Yu S; Russell MW; Agarwal PP; Mahani MG; Lu JC
    Am J Cardiol; 2014 Apr; 113(7):1234-9. PubMed ID: 24513464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
    Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
    Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of regional ejection fraction in patients with myocardial infarction by using merged late gadolinium enhancement and cine MR: feasibility study.
    Masci PG; Dymarkowski S; Rademakers FE; Bogaert J
    Radiology; 2009 Jan; 250(1):50-60. PubMed ID: 19092090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.